250 related articles for article (PubMed ID: 32800410)
1. Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method.
Arita T; Kondo J; Kaneko Y; Tsutsumi M; Kanemaru M; Matsui M; Arakawa Y; Katoh N; Inoue M; Asai J
J Dermatol Sci; 2020 Sep; 99(3):185-192. PubMed ID: 32800410
[TBL] [Abstract][Full Text] [Related]
2. Extramammary Paget's disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.
Maeda T; Kitamura S; Nishihara H; Yanagi T
Oncogene; 2020 Sep; 39(36):5867-5875. PubMed ID: 32724160
[TBL] [Abstract][Full Text] [Related]
3. Topical imiquimod in the treatment of extramammary Paget's disease: A 10 year retrospective analysis in an Asian tertiary centre.
Liau MM; Yang SS; Tan KB; Aw CW
Dermatol Ther; 2016 Nov; 29(6):459-462. PubMed ID: 27526657
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Mao HR
Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449
[TBL] [Abstract][Full Text] [Related]
5. KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.
Ito T; Tanaka Y; Ichiki T; Kaku-Ito Y; Nakahara T
Hum Cell; 2023 Sep; 36(5):1813-1829. PubMed ID: 37432591
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.
Kitamura S; Yanagi T; Maeda T; Ujiie H
Cancer Sci; 2022 Feb; 113(2):802-807. PubMed ID: 34866279
[TBL] [Abstract][Full Text] [Related]
7. Weekly docetaxel monotherapy for metastatic extramammary Paget's disease: Retrospective single-institute analysis.
Nakamura Y; Tanese K; Hirai I; Fukuda K; Kawakami Y; Amagai M; Funakoshi T
J Dermatol; 2020 Apr; 47(4):418-422. PubMed ID: 32020662
[TBL] [Abstract][Full Text] [Related]
8. [Observations on signet cell invasion and metastasis in extra-mammary Paget's disease].
Xu H; Li N; Li W
Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):294-5. PubMed ID: 9388876
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
[TBL] [Abstract][Full Text] [Related]
10. Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
Hirai I; Funakoshi T
J Dermatol; 2017 Oct; 44(10):1148-1151. PubMed ID: 28406527
[TBL] [Abstract][Full Text] [Related]
11. Spheroid culture of primary lung cancer cells with neuregulin 1/HER3 pathway activation.
Endo H; Okami J; Okuyama H; Kumagai T; Uchida J; Kondo J; Takehara T; Nishizawa Y; Imamura F; Higashiyama M; Inoue M
J Thorac Oncol; 2013 Feb; 8(2):131-9. PubMed ID: 23328545
[TBL] [Abstract][Full Text] [Related]
12. Treatment of limited extent extramammary Paget's disease with 5 percent imiquimod cream.
Badgwell C; Rosen T
Dermatol Online J; 2006 Jan; 12(1):22. PubMed ID: 16638390
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.
Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M
Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523
[TBL] [Abstract][Full Text] [Related]
14. Treatment of mammary and extramammary Paget's skin disease with topical imiquimod.
Mirer E; El Sayed F; Ammoury A; Lamant L; Messer L; Bazex J
J Dermatolog Treat; 2006; 17(3):167-71. PubMed ID: 16854759
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.
Tsutsui K; Takahashi A; Muto Y; Mizuta H; Jinnai S; Nakama K; Ogata D; Namikawa K; Yamazaki N
J Dermatol; 2020 May; 47(5):512-517. PubMed ID: 32157716
[TBL] [Abstract][Full Text] [Related]
16. NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.
Murata M; Ito T; Tanaka Y; Kaku-Ito Y; Furue M
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824340
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease.
Sawada M; Kato J; Yamashita T; Yoneta A; Hida T; Horimoto K; Sato S; Uhara H
J Dermatol; 2018 Feb; 45(2):216-219. PubMed ID: 29115681
[TBL] [Abstract][Full Text] [Related]
18. Trop2 Expression in Extramammary Paget's Disease and Normal Skin.
Ito T; Tanegashima K; Tanaka Y; Hashimoto H; Murata M; Oda Y; Kaku-Ito Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299325
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of three cases of primary extramammary Paget's disease of the vulva with Imiquimod--proposal of a therapeutic schedule.
Sendagorta E; Herranz P; Feito M; Ramírez P; Floristán U; Feltes R; Benito DM; Casado M
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):490-2. PubMed ID: 19840203
[TBL] [Abstract][Full Text] [Related]
20. Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic target.
Nakamura Y; Mizukami H; Tanese K; Fusumae T; Hirai I; Amagai M; Takamatsu R; Nakamura K; Nishihara H; Takimoto T; Ueno M; Saya H; Funakoshi T
J Dermatol Sci; 2023 Oct; 112(1):23-30. PubMed ID: 37661472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]